The Trump administration is ending a Medicare drug subsidy program. Here's how it could affect costs - AOL

Millions of Medicare beneficiaries could see higher monthly prescription drug costs in 2027 after the Trump administration ends a temporary Part D subsidy program. The Centers for Medicare & Medicaid Services said it will close the program, introduced by the Biden administration in 2024 to reduce Medicare Part D premiums after the 2022 Inflation Reduction Act. CMS estimates the impact on beneficiaries will be limited, but the decision arrives during a midterm election year when voters are focused on cost of living. About 25 million people with Part D plans will learn their 2027 rates in the fall. CMS Administrator Dr. Mehmet Oz said the agency spent about $3.6 billion in 2026, while most beneficiaries would see less than a $10-per-month increase.